Dietary  ||| S:0 E:8 ||| JJ
energy  ||| S:8 E:15 ||| NN
source  ||| S:15 E:22 ||| NN
and  ||| S:22 E:26 ||| CC
physical  ||| S:26 E:35 ||| JJ
conditioning  ||| S:35 E:48 ||| NNS
affect  ||| S:48 E:55 ||| VBP
insulin  ||| S:55 E:63 ||| JJ
sensitivity  ||| S:63 E:75 ||| NN
and  ||| S:75 E:79 ||| CC
skeletal  ||| S:79 E:88 ||| FW
muscle  ||| S:88 E:95 ||| FW
glucose  ||| S:95 E:103 ||| FW
metabolism  ||| S:103 E:114 ||| FW
in  ||| S:114 E:117 ||| FW
horses  ||| S:117 E:124 ||| FW
Starch  ||| S:124 E:131 ||| FW
rich  ||| S:131 E:136 ||| FW
( ||| S:136 E:137 ||| -LRB-
S ||| S:137 E:138 ||| NNP
)  ||| S:138 E:140 ||| -RRB-
feeds  ||| S:140 E:146 ||| VBZ
reduce  ||| S:146 E:153 ||| VB
insulin  ||| S:153 E:161 ||| NN
sensitivity  ||| S:161 E:173 ||| NN
in  ||| S:173 E:176 ||| IN
untrained  ||| S:176 E:186 ||| JJ
horses  ||| S:186 E:193 ||| NNS
when  ||| S:193 E:198 ||| WRB
compared  ||| S:198 E:207 ||| VBN
to  ||| S:207 E:210 ||| TO
high  ||| S:210 E:215 ||| JJ
fat  ||| S:215 E:219 ||| JJ
( ||| S:219 E:220 ||| -LRB-
F ||| S:220 E:221 ||| NNP
)  ||| S:221 E:223 ||| -RRB-
feeds ||| S:223 E:228 ||| VBZ
,  ||| S:228 E:230 ||| ,
but  ||| S:230 E:234 ||| CC
insulin  ||| S:234 E:242 ||| NN
sensitivity  ||| S:242 E:254 ||| NN
is  ||| S:254 E:257 ||| VBZ
not  ||| S:257 E:261 ||| RB
affected  ||| S:261 E:270 ||| VBN
when  ||| S:270 E:275 ||| WRB
S  ||| S:275 E:277 ||| NNP
or  ||| S:277 E:280 ||| CC
F  ||| S:280 E:282 ||| NN
are  ||| S:282 E:286 ||| VBP
fed  ||| S:286 E:290 ||| VBN
during  ||| S:290 E:297 ||| IN
exercise  ||| S:297 E:306 ||| NN
training ||| S:306 E:314 ||| NN
.  ||| S:314 E:316 ||| .
The  ||| S:316 E:320 ||| DT
effects  ||| S:320 E:328 ||| NNS
of  ||| S:328 E:331 ||| IN
S  ||| S:331 E:333 ||| NNP
vs.  ||| S:333 E:337 ||| FW
F  ||| S:337 E:339 ||| NN
on  ||| S:339 E:342 ||| IN
training-associated  ||| S:342 E:362 ||| JJ
alterations  ||| S:362 E:374 ||| NN
in  ||| S:374 E:377 ||| IN
skeletal  ||| S:377 E:386 ||| JJ
muscle  ||| S:386 E:393 ||| NN
glucose  ||| S:393 E:401 ||| NN
metabolism  ||| S:401 E:412 ||| NNS
are  ||| S:412 E:416 ||| VBP
unknown ||| S:416 E:423 ||| JJ
.  ||| S:423 E:425 ||| .
To  ||| S:425 E:428 ||| TO
determine  ||| S:428 E:438 ||| VB
the  ||| S:438 E:442 ||| DT
effects  ||| S:442 E:450 ||| NNS
of  ||| S:450 E:453 ||| IN
dietary  ||| S:453 E:461 ||| JJ
energy  ||| S:461 E:468 ||| NN
source  ||| S:468 E:475 ||| NN
on  ||| S:475 E:478 ||| IN
training-associated  ||| S:478 E:498 ||| JJ
changes  ||| S:498 E:506 ||| NNS
in  ||| S:506 E:509 ||| IN
insulin  ||| S:509 E:517 ||| NN
sensitivity ||| S:517 E:528 ||| NN
,  ||| S:528 E:530 ||| ,
skeletal  ||| S:530 E:539 ||| JJ
muscle  ||| S:539 E:546 ||| NN
GLUT4  ||| S:546 E:552 ||| CD
protein  ||| S:552 E:560 ||| NN
and  ||| S:560 E:564 ||| CC
hexokinase  ||| S:564 E:575 ||| NNS
( ||| S:575 E:576 ||| -LRB-
HK ||| S:576 E:578 ||| NNP
)  ||| S:578 E:580 ||| -RRB-
and  ||| S:580 E:584 ||| CC
glycogen  ||| S:584 E:593 ||| JJ
synthase  ||| S:593 E:602 ||| NNS
( ||| S:602 E:603 ||| -LRB-
GS ||| S:603 E:605 ||| NNP
)  ||| S:605 E:607 ||| -RRB-
activities  ||| S:607 E:618 ||| NNS
in  ||| S:618 E:621 ||| IN
horses ||| S:621 E:627 ||| NNS
.  ||| S:627 E:629 ||| .
After  ||| S:629 E:635 ||| IN
a  ||| S:635 E:637 ||| DT
baseline  ||| S:637 E:646 ||| NN
period  ||| S:646 E:653 ||| NN
on  ||| S:653 E:656 ||| IN
an  ||| S:656 E:659 ||| DT
all  ||| S:659 E:663 ||| DT
forage  ||| S:663 E:670 ||| JJ
diet  ||| S:670 E:675 ||| NN
( ||| S:675 E:676 ||| -LRB-
Phase  ||| S:676 E:682 ||| NNP
1 ||| S:682 E:683 ||| CD
) ||| S:683 E:684 ||| -RRB-
,  ||| S:684 E:686 ||| ,
horses  ||| S:686 E:693 ||| NNS
were  ||| S:693 E:698 ||| VBD
adapted  ||| S:698 E:706 ||| VBN
to  ||| S:706 E:709 ||| TO
high  ||| S:709 E:714 ||| JJ
starch  ||| S:714 E:721 ||| NNS
( ||| S:721 E:722 ||| -LRB-
S ||| S:722 E:723 ||| NNP
)  ||| S:723 E:725 ||| -RRB-
or  ||| S:725 E:728 ||| CC
high  ||| S:728 E:733 ||| JJ
fat  ||| S:733 E:737 ||| JJ
( ||| S:737 E:738 ||| -LRB-
F ||| S:738 E:739 ||| NNP
)  ||| S:739 E:741 ||| -RRB-
diets  ||| S:741 E:747 ||| NNS
( ||| S:747 E:748 ||| -LRB-
n  ||| S:748 E:750 ||| CD
=  ||| S:750 E:752 ||| SYM
7 ||| S:752 E:753 ||| CD
/ ||| S:753 E:754 ||| CD
group ||| S:754 E:759 ||| NN
)  ||| S:759 E:761 ||| -RRB-
for  ||| S:761 E:765 ||| IN
6  ||| S:765 E:767 ||| CD
weeks  ||| S:767 E:773 ||| NNS
( ||| S:773 E:774 ||| -LRB-
Phase  ||| S:774 E:780 ||| NNP
2 ||| S:780 E:781 ||| CD
)  ||| S:781 E:783 ||| -RRB-
and  ||| S:783 E:787 ||| CC
then  ||| S:787 E:792 ||| RB
completed  ||| S:792 E:802 ||| VBD
7  ||| S:802 E:804 ||| CD
weeks  ||| S:804 E:810 ||| NNS
of  ||| S:810 E:813 ||| IN
exercise  ||| S:813 E:822 ||| NN
training  ||| S:822 E:831 ||| NN
( ||| S:831 E:832 ||| -LRB-
Phase  ||| S:832 E:838 ||| NNP
3 ||| S:838 E:839 ||| CD
)  ||| S:839 E:841 ||| -RRB-
on  ||| S:841 E:844 ||| IN
the  ||| S:844 E:848 ||| DT
same  ||| S:848 E:853 ||| JJ
diets ||| S:853 E:858 ||| NN
.  ||| S:858 E:860 ||| .
To  ||| S:860 E:863 ||| TO
measure  ||| S:863 E:871 ||| VB
insulin  ||| S:871 E:879 ||| NN
sensitivity  ||| S:879 E:891 ||| NN
( ||| S:891 E:892 ||| -LRB-
SI ||| S:892 E:894 ||| NNP
) ||| S:894 E:895 ||| -RRB-
,  ||| S:895 E:897 ||| ,
minimal  ||| S:897 E:905 ||| JJ
model  ||| S:905 E:911 ||| NN
analysis  ||| S:911 E:920 ||| NN
of  ||| S:920 E:923 ||| IN
a  ||| S:923 E:925 ||| DT
frequently-sampled  ||| S:925 E:944 ||| JJ
i.v.  ||| S:944 E:949 ||| CD
glucose  ||| S:949 E:957 ||| JJ
tolerance  ||| S:957 E:967 ||| NN
test  ||| S:967 E:972 ||| NN
was  ||| S:972 E:976 ||| VBD
performed  ||| S:976 E:986 ||| VBN
at  ||| S:986 E:989 ||| IN
the  ||| S:989 E:993 ||| DT
end  ||| S:993 E:997 ||| NN
of  ||| S:997 E:1000 ||| IN
each  ||| S:1000 E:1005 ||| DT
phase ||| S:1005 E:1010 ||| NN
.  ||| S:1010 E:1012 ||| .
Middle  ||| S:1012 E:1019 ||| JJ
gluteal  ||| S:1019 E:1027 ||| JJ
muscle  ||| S:1027 E:1034 ||| NN
biopsies  ||| S:1034 E:1043 ||| NNS
to  ||| S:1043 E:1046 ||| TO
measure  ||| S:1046 E:1054 ||| VB
GLUT-4  ||| S:1054 E:1061 ||| CD
protein  ||| S:1061 E:1069 ||| NN
content ||| S:1069 E:1076 ||| NN
,  ||| S:1076 E:1078 ||| ,
muscle  ||| S:1078 E:1085 ||| NN
glycogen  ||| S:1085 E:1094 ||| NNS
and  ||| S:1094 E:1098 ||| CC
HK  ||| S:1098 E:1101 ||| NNP
and  ||| S:1101 E:1105 ||| CC
GS  ||| S:1105 E:1108 ||| NNP
activities  ||| S:1108 E:1119 ||| NNS
were  ||| S:1119 E:1124 ||| VBD
taken  ||| S:1124 E:1130 ||| VBN
before  ||| S:1130 E:1137 ||| IN
and  ||| S:1137 E:1141 ||| CC
after  ||| S:1141 E:1147 ||| IN
euglycaemic-hyperinsulinaemic  ||| S:1147 E:1177 ||| JJ
clamps  ||| S:1177 E:1184 ||| NNS
administered  ||| S:1184 E:1197 ||| VBN
after  ||| S:1197 E:1203 ||| IN
each  ||| S:1203 E:1208 ||| DT
phase ||| S:1208 E:1213 ||| NN
.  ||| S:1213 E:1215 ||| .
Data  ||| S:1215 E:1220 ||| NNP
were  ||| S:1220 E:1225 ||| VBD
analysed  ||| S:1225 E:1234 ||| VBN
by  ||| S:1234 E:1237 ||| IN
repeated  ||| S:1237 E:1246 ||| JJ
measures  ||| S:1246 E:1255 ||| NNS
ANOVA ||| S:1255 E:1260 ||| NNP
.  ||| S:1260 E:1262 ||| .
In  ||| S:1262 E:1265 ||| IN
S ||| S:1265 E:1266 ||| NNP
,  ||| S:1266 E:1268 ||| ,
SI  ||| S:1268 E:1271 ||| NNP
was  ||| S:1271 E:1275 ||| VBD
36 ||| S:1275 E:1277 ||| CD
%  ||| S:1277 E:1279 ||| NN
lower  ||| S:1279 E:1285 ||| RBR
( ||| S:1285 E:1286 ||| -LRB-
P  ||| S:1286 E:1288 ||| NNP
< ||| S:1288 E:1290 ||| SYM
0.05 ||| S:1290 E:1294 ||| CD
)  ||| S:1294 E:1296 ||| -RRB-
after  ||| S:1296 E:1302 ||| IN
Phase  ||| S:1302 E:1308 ||| NNP
2  ||| S:1308 E:1310 ||| CD
when  ||| S:1310 E:1315 ||| WRB
compared  ||| S:1315 E:1324 ||| VBN
to  ||| S:1324 E:1327 ||| TO
Phase  ||| S:1327 E:1333 ||| NNP
1  ||| S:1333 E:1335 ||| CD
but  ||| S:1335 E:1339 ||| CC
was  ||| S:1339 E:1343 ||| VBD
unchanged  ||| S:1343 E:1353 ||| JJ
in  ||| S:1353 E:1356 ||| IN
F.  ||| S:1356 E:1359 ||| NNP
After  ||| S:1359 E:1365 ||| IN
Phase  ||| S:1365 E:1371 ||| NNP
3 ||| S:1371 E:1372 ||| CD
,  ||| S:1372 E:1374 ||| ,
SI  ||| S:1374 E:1377 ||| NNP
was  ||| S:1377 E:1381 ||| VBD
increased  ||| S:1381 E:1391 ||| VBN
( ||| S:1391 E:1392 ||| -LRB-
P  ||| S:1392 E:1394 ||| NNP
< ||| S:1394 E:1396 ||| SYM
0.01 ||| S:1396 E:1400 ||| CD
)  ||| S:1400 E:1402 ||| -RRB-
in  ||| S:1402 E:1405 ||| IN
S  ||| S:1405 E:1407 ||| NNP
and  ||| S:1407 E:1411 ||| CC
F  ||| S:1411 E:1413 ||| NN
compared  ||| S:1413 E:1422 ||| VBN
to  ||| S:1422 E:1425 ||| TO
Phase  ||| S:1425 E:1431 ||| NNP
2  ||| S:1431 E:1433 ||| CD
and  ||| S:1433 E:1437 ||| CC
did  ||| S:1437 E:1441 ||| VBD
not  ||| S:1441 E:1445 ||| RB
differ  ||| S:1445 E:1452 ||| VB
( ||| S:1452 E:1453 ||| -LRB-
P  ||| S:1453 E:1455 ||| NNP
>  ||| S:1455 E:1457 ||| CD
0.05 ||| S:1457 E:1461 ||| CD
)  ||| S:1461 E:1463 ||| -RRB-
between  ||| S:1463 E:1471 ||| IN
diets ||| S:1471 E:1476 ||| NN
.  ||| S:1476 E:1478 ||| .
Middle  ||| S:1478 E:1485 ||| JJ
gluteal  ||| S:1485 E:1493 ||| JJ
muscle  ||| S:1493 E:1500 ||| NN
GLUT-4  ||| S:1500 E:1507 ||| CD
protein  ||| S:1507 E:1515 ||| NN
and  ||| S:1515 E:1519 ||| CC
post  ||| S:1519 E:1524 ||| VB
clamp  ||| S:1524 E:1530 ||| JJ
HK  ||| S:1530 E:1533 ||| NNP
activity  ||| S:1533 E:1542 ||| NN
were  ||| S:1542 E:1547 ||| VBD
increased  ||| S:1547 E:1557 ||| VBN
( ||| S:1557 E:1558 ||| -LRB-
P  ||| S:1558 E:1560 ||| NNP
< ||| S:1560 E:1562 ||| SYM
0.05 ||| S:1562 E:1566 ||| CD
)  ||| S:1566 E:1568 ||| -RRB-
in  ||| S:1568 E:1571 ||| IN
S  ||| S:1571 E:1573 ||| NNP
after  ||| S:1573 E:1579 ||| IN
Phase  ||| S:1579 E:1585 ||| NNP
3 ||| S:1585 E:1586 ||| CD
,  ||| S:1586 E:1588 ||| ,
with  ||| S:1588 E:1593 ||| IN
higher  ||| S:1593 E:1600 ||| JJR
( ||| S:1600 E:1601 ||| -LRB-
P  ||| S:1601 E:1603 ||| NNP
< ||| S:1603 E:1605 ||| SYM
0.01 ||| S:1605 E:1609 ||| CD
)  ||| S:1609 E:1611 ||| -RRB-
GLUT4  ||| S:1611 E:1617 ||| CD
in  ||| S:1617 E:1620 ||| IN
S  ||| S:1620 E:1622 ||| NNP
than  ||| S:1622 E:1627 ||| IN
in  ||| S:1627 E:1630 ||| IN
F.  ||| S:1630 E:1633 ||| NNP
GS  ||| S:1633 E:1636 ||| NNP
activities  ||| S:1636 E:1647 ||| NNS
were  ||| S:1647 E:1652 ||| VBD
unchanged  ||| S:1652 E:1662 ||| JJ
in  ||| S:1662 E:1665 ||| IN
both  ||| S:1665 E:1670 ||| DT
diets ||| S:1670 E:1675 ||| NN
.  ||| S:1675 E:1677 ||| .
Adaptation  ||| S:1677 E:1688 ||| NN
to  ||| S:1688 E:1691 ||| TO
S  ||| S:1691 E:1693 ||| NNP
resulted  ||| S:1693 E:1702 ||| VBD
in  ||| S:1702 E:1705 ||| IN
decreased  ||| S:1705 E:1715 ||| JJ
SI  ||| S:1715 E:1718 ||| NNP
mitigated  ||| S:1718 E:1728 ||| NN
by  ||| S:1728 E:1731 ||| IN
moderate  ||| S:1731 E:1740 ||| JJ
physical  ||| S:1740 E:1749 ||| JJ
conditioning ||| S:1749 E:1761 ||| NN
.  ||| S:1761 E:1763 ||| .
Increased  ||| S:1763 E:1773 ||| VBN
GLUT-4  ||| S:1773 E:1780 ||| CD
protein  ||| S:1780 E:1788 ||| NN
content  ||| S:1788 E:1796 ||| NN
and  ||| S:1796 E:1800 ||| CC
HK  ||| S:1800 E:1803 ||| NNP
activity  ||| S:1803 E:1812 ||| NN
in  ||| S:1812 E:1815 ||| IN
S  ||| S:1815 E:1817 ||| NNP
may  ||| S:1817 E:1821 ||| MD
have  ||| S:1821 E:1826 ||| VB
contributed  ||| S:1826 E:1838 ||| VBN
to  ||| S:1838 E:1841 ||| TO
higher  ||| S:1841 E:1848 ||| JJR
SI  ||| S:1848 E:1851 ||| NN
after  ||| S:1851 E:1857 ||| IN
training ||| S:1857 E:1865 ||| NN
.  ||| S:1865 E:1867 ||| .
